secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO-RAD LABORATORIES, INC. (BIO)
CIK:        0000012208
Form:       8-K
Filed at:   2024-04-10T23:59:59+00:00
Accession:  0000012208-24-000025
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bio-Rad COO Andrew Last to retire by early September 2024; successor search underway
--------------------------------------------------------------------------------

- Dr. Andrew Last notified Bio-Rad of his retirement from EVP and COO role on April 10, 2024.
- He will remain in his position through early September to ensure a smooth transition.
- CEO Norman Schwartz credited Last with progress on cost structure, core processes, and supply chain.
- Bio-Rad has started a search for Last's successor.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/12208/000001220824000025/0000012208-24-000025-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/12208/000001220824000025/bio-20240410.htm
  HTML page:      https://secwatch.observer/filing/0000012208-24-000025

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer